You just read:

Rock Creek Pharmaceuticals Announces Successful Completion of Phase I Clinical Trial to Evaluate Oral Formulations of its Lead Compound, Plans to Conduct Proof-of-Concept Trial in Subjects with Mild to Moderate Psoriasis

News provided by

Rock Creek Pharmaceuticals, Inc.

15 Oct, 2015, 14:54 BST